共 50 条
COST EFFECTIVENESS OF PEMETREXED/CISPLATIN (PEM/CIS) IN THE TREATMENT OF ADVANCED, NON-SQUAMOUS, NON-SMALL CELL LUNG CANCER (NSQNSCLC) PATIENTS
被引:0
|作者:
Winfree, K. B.
[1
]
Shah, M.
[2
]
Peterson, P.
[3
]
Gruschkus, S.
[2
]
Eaddy, M.
[2
]
Green, M.
[2
]
机构:
[1] Eli Lilly & Co, Global Hlth Outcomes Oncol, Indianapolis, IN 46285 USA
[2] Xcenda AmerisourceBergen Consulting Serv, Oncol, Palm Harbor, FL USA
[3] Eli Lilly & Co, Oncol Stat, Indianapolis, IN 46285 USA
关键词:
D O I:
暂无
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
引用
收藏
页码:428 / 428
页数:1
相关论文